Umin-ctr clinical trial




















Contact us. Glossary Simple. Search clinical trials. Recruitment status. Effect of Empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: Multi-Center placebo-controlled Double-Blind Randomized Trial.

Date of disclosure of the study information. Last modified on. Basic information. Scientific Title. Scientific Title:Acronym. Type 2 diabetes with acute myocardial infarction. Classification by specialty. Classification by malignancy. Genomic information. Narrative objectives1. I: Primary objective is to investigate that empagliflozin add-on to the conventional therapy improves heart rate variability HRV assessed by Ambulatory ECG SCM , a surrogate maker of lethal ventricular tachyarrhythmias in comparison with placebo.

Basic objectives2. Basic objectives -Others. Developmental phase. Primary outcomes. Key secondary outcomes. Study design.

Randomization unit. Double blind -all involved are blinded. Dynamic allocation. Institution consideration. Purpose of intervention. Basic objectives -Others. Developmental phase. Phase II. Primary outcomes. Primary endpoint: response rate.

Key secondary outcomes. Study design. Single arm. Randomization unit. Open -no one is blinded. Dynamic allocation. Institution consideration. Purpose of intervention. Type of intervention. Patients receive oral mg gefitinib daily until disease progression. Age-lower limit. Age-upper limit. Male and Female. Key inclusion criteria. Key exclusion criteria. Target sample size. Research contact person. Name of lead principal investigator.

Department of Thoracic Malignancy. Public contact. Name of contact person. West Japan Oncology Group. Funding Source. Key secondary outcomes. Study design. Randomization unit. Double blind -all involved are blinded. Dynamic allocation. Institution consideration. Purpose of intervention. Type of intervention. Age-lower limit. Age-upper limit. Key inclusion criteria. Key exclusion criteria. Target sample size. Research contact person. Name of lead principal investigator.

Hokkaido University Hospital. Public contact. Name of contact person. Funding Source. Amino Up Co. Category of Funding Organization. Profit organization. Nationality of Funding Organization. Other related organizations. Name of secondary funder s. IRB Contact For public release.



0コメント

  • 1000 / 1000